Qureator, Inc.

  • Qureator’s Microphysiological systems (MPS) provide high-throughput 3D disease-relevant phenotypic models to recapitulate important physiological characteristics and reproduce complex disease states using human cells.
  • Homepage : www.qureator.com
  • Recent Financing Round : $15 Million Series A in April 2022
  • Other Investors : Winvest Venture Capital, HG Initiative (HGI)
  • Portfolio company : SparkLabs Korea



BACK Website